Menu
Back to Journals » OncoTargets and Therapy » Volume 7
Original Research
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 10,195 | Dovepress* | 7,459 | 1,153+ | 1,652 | 8,612 |
| PubMed Central* | 7 | 1,576 | 439 | 1,583 | |
| Totals | 7,466 | 2,729 | 2,091 | 10,195 | |
|
*Since 16 January 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar